These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37172278)

  • 1. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment.
    Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
    Cell Reprogram; 2023 Jun; 25(3):91-98. PubMed ID: 37172278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
    Fukushi A; Kim HD; Chang YC; Kim CH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma.
    Reuss AM; Groos D; Buchfelder M; Savaskan N
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors.
    Gupta S; Dwarakanath BS
    Curr Med Chem; 2020; 27(24):4002-4015. PubMed ID: 29852858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.
    Zhou J; Ma X; Liu X; Liu Y; Fu J; Qi Y; Liu H
    Genes Genomics; 2024 Sep; 46(9):991-1011. PubMed ID: 39127851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
    Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
    Tan S; Yang Y; Yang W; Han Y; Huang L; Yang R; Hu Z; Tao Y; Liu L; Li Y; Oyang L; Lin J; Peng Q; Jiang X; Xu X; Xia L; Peng M; Wu N; Tang Y; Cao D; Liao Q; Zhou Y
    J Exp Clin Cancer Res; 2023 Mar; 42(1):59. PubMed ID: 36899389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory roles and clinical significance of glycolysis in tumor.
    Qiao Q; Hu S; Wang X
    Cancer Commun (Lond); 2024 Jul; 44(7):761-786. PubMed ID: 38851859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment.
    Fridman ES; Ginini L; Gil Z
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate in the tumour microenvironment: From immune modulation to therapy.
    Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
    EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Warburg Effect in Cancer: Where Do We Stand?
    Barba I; Carrillo-Bosch L; Seoane J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism.
    Vahabi M; Comandatore A; Franczak MA; Smolenski RT; Peters GJ; Morelli L; Giovannetti E
    Cytokine Growth Factor Rev; 2023 Oct; 73():163-172. PubMed ID: 37541790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration.
    Kolb D; Kolishetti N; Surnar B; Sarkar S; Guin S; Shah AS; Dhar S
    ACS Nano; 2020 Sep; 14(9):11055-11066. PubMed ID: 32706241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
    Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
    Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolytic enzymes in non-glycolytic web: functional analysis of the key players.
    Malla A; Gupta S; Sur R
    Cell Biochem Biophys; 2024 Jun; 82(2):351-378. PubMed ID: 38196050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.